| No |
Initial |
Age at dx |
Phase |
Sokal’s risk |
Mutation at diagnosis |
Response |
| P-loop |
Outside P-loop |
| 1 |
PP |
28 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 2 |
N |
24 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 3 |
AL |
38 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 4 |
JR |
61 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 5 |
F |
24 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 6 |
SR |
45 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 7 |
M |
36 |
Chronic |
High |
NM |
n.1152 C→T(silent mutation) |
Drop out |
| 8 |
KKK (†) |
47 |
Chronic |
Intermediate |
NM |
V506S |
No response |
| 9 |
UBW (†) |
54 |
Chronic |
High |
NM |
N231Q |
No response |
| 10 |
A (†) |
45 |
Chronic |
High |
NM |
c.661_662insG and c.1555_1557insG |
No response |
| 11 |
I |
59 |
Accelerated |
Low |
NM |
NM |
CHR in 4 to 6 months |
| 12 |
AP |
20 |
Accelerated |
High |
NM |
NM |
CHR in 10 to 12 months |
| 13 |
AH (†) |
50 |
Accelerated |
High |
NM |
E509G |
No response |
| 14 |
H (†) |
41 |
Blast crisis |
High |
NM |
NM |
No response |
| 15 |
M (†) |
51 |
Chronic |
High |
NM |
NM |
No response |
| 16 |
TS |
56 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 17 |
S |
32 |
Chronic |
High |
NM |
NM |
CHR in 7 to 9 months |
| 18 |
ME |
32 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 19 |
MFA (†) |
39 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 20 |
ES |
34 |
Accelerated |
High |
NM |
NM |
CHR within 3 months |
| 21 |
PR |
39 |
Accelerated |
High |
NM |
NM |
CHR in 4 to 6 months |
| 22 |
S (†) |
21 |
Blast crisis |
High |
NM |
NM |
No response |
| 23 |
TF |
26 |
Blast crisis |
High |
NM |
NM |
CHR within 3 months |
| 24 |
MA |
34 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 25 |
YNK |
40 |
Chronic |
Intermediate |
NM |
NM |
Not determined |
| 26 |
WG |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 27 |
HY |
|
Chronic |
High |
NM |
M351T |
Died of blastic crisis |
| 28 |
Was |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 29 |
WF |
|
Chronic |
Intermediate |
NM |
NM |
Died of blastic crisis |
| 30 |
UK |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
| 31 |
TF |
|
Blast crisis |
High |
NM |
NM |
Not MMR |
| 32 |
TA |
|
Blast crisis |
High |
NM |
NM |
CHR within 3 months |
| 33 |
Syaf |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 34 |
Sur |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 35 |
Sol |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
| 36 |
SA |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
| 37 |
RP |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
| 38 |
RSu |
|
Accelerated |
High |
NM |
NM |
CHR within 3 months |
| 39 |
R So |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
| 40 |
RY |
|
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 41 |
PR |
|
Accelerated |
High |
NM |
NM |
CHR within 3 months |
| 42 |
NM |
|
Accelated |
High |
NM |
NM |
No MMR, but still alive |
| 43 |
NS |
|
Chronic |
High |
NM |
NM |
CHR within 3 months |
| 44 |
TS |
|
Chronic |
Intermediate |
Y253H |
NM |
Died during 15 mo’s IM treatment |
| *NM: no mutation |
|